Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2012
09/26/2012CN102688218A Chitosan capsule shell and preparation method thereof
09/26/2012CN102688216A Gabapentin tablet and preparation method thereof
09/26/2012CN102688213A Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
09/26/2012CN102688212A Isosorbide mononitrate sustained release tablet and preparation method thereof
09/26/2012CN102688211A Levocarnitine osmotic pump slow and controlled-release tablet and preparation method thereof
09/26/2012CN102688207A Novel pharmaceutical composition
09/26/2012CN102688206A Pitavastatin calcium tablet and preparation method thereof
09/26/2012CN102688203A Alprostadil freeze-dried powder injection and preparation method thereof
09/26/2012CN102688202A Temozolomide freeze-dried preparation
09/26/2012CN102688200A Plant anti-cancer targeting nano-preparation, and preparation method thereof
09/26/2012CN102688198A Polypeptide drug sustained-release microsphere preparation and preparation method thereof
09/26/2012CN102688197A Florfenicol water soluble particles and preparation method thereof
09/26/2012CN102688195A Preparation method for doxorubicin hydrochloride-entrapped chitosan carboxymethyl chitosan nanometer controlled-release particle with pH sensibility
09/26/2012CN102688192A Sustained-release preparation of polypeptide drug for treating diabetes and production method thereof
09/26/2012CN102688191A Medicine composition containing vitamin K1 and oil
09/26/2012CN102688190A Preparation for oral administration of oleanolic acid solid lipid nanoparticle and transport mechanism thereof
09/26/2012CN102688188A maleic acid cinepazide injection and preparation method thereof
09/26/2012CN102688187A Fructose medicament composition injection and preparation method thereof
09/26/2012CN102688186A Medicine composition containing vinpocetine raw material
09/26/2012CN102688185A Stable palonosetron injection and preparation method thereof
09/26/2012CN102687964A Method for strengthening drug slow release property in summer sleeping mat
09/26/2012CN102327237B Azasetron hydrochloride lipidosome injection
09/26/2012CN102327220B Solid loratadine lipidosome preparation
09/26/2012CN102266289B Cilnidipine liposome solid preparation
09/26/2012CN102266287B Folate-receptor-mediated curcumin self-microemulsion colon-specific delivery preparation
09/26/2012CN102247331B Cefadroxil chewable tablets and preparation method thereof
09/26/2012CN102178891B Chinese medicinal dispersible tablets for treating gastritis and preparation method thereof
09/26/2012CN102178651B Tretinoin fat emulsion injection and preparation method thereof
09/26/2012CN102174123B Production method of water soluble flavone-chitosan derivative
09/26/2012CN102166208B Lisinopril and hydrochlorothiazide pharmaceutical composition liposome solid preparation
09/26/2012CN102145178B PEG interleukin 15
09/26/2012CN102145172B Composition for improving absorbance of aminoglycoside drug
09/26/2012CN102144970B Alprostadil lipid nanosphere injection and preparation method thereof
09/26/2012CN102144968B Oral suspension of liposome-encapsulated insulin lyophilized preparation and preparation process thereof
09/26/2012CN102127298B Polymer hollow nano microspheres and preparation method thereof
09/26/2012CN102091043B Growth factor slow release microballoon and preparation method thereof
09/26/2012CN102008447B Entecavir solid dispersion and preparation thereof
09/26/2012CN101974089B Recombination fusion protein Trx-TAT-hMsrA and application thereof to aspect of nerve cell protection
09/26/2012CN101934081B Magnetic nano lamellar hydroxyapatite and DNA composite as well as preparation method and application thereof
09/26/2012CN101912395B Medical composite containing pirfenidone and preparation method thereof
09/26/2012CN101912357B Gel paste preparation and preparation method thereof
09/26/2012CN101878857B Aloe polysaccharide powder and preparation method thereof
09/26/2012CN101875700B Method for improving bioactivity of exendin fusion protein
09/26/2012CN101861169B Stabilisation of oily suspensions containing hydrophobic silicic acids
09/26/2012CN101757632B Soft capsule shell composition and application thereof
09/26/2012CN101744777B Omeprazole sodium freeze-dried powder injection, as well as preparation method and quality control method thereof
09/26/2012CN101732251B Oxiracetam liposome injection
09/26/2012CN101711755B Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
09/26/2012CN101621999B Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same
09/26/2012CN101569759B Isotonic collagen sponge and preparation method thereof
09/26/2012CN101491501B Preparation method of ambroxol for injection
09/26/2012CN101420943B Chewing composition containing coenzyme q10
09/26/2012CN101163506B Polymer-von willebrand factor-conjugates
09/26/2012CN101120955B Enteric coated preparation containing glossy ganoderma spore powder active ingredient
09/25/2012US8273833 Branched Polymers
09/25/2012US8273798 Tamper resistant lipid-based oral dosage form for opioid agonists
09/25/2012US8273728 Preformulation for tabletting natural mixtures of conjugated estrogens
09/25/2012US8273711 Topical drug delivery using phosphatidylcholine
09/25/2012US8273708 Regulation of paracellular permeability of the ocular surface epithelium, corresponding to the anterior segment of the eye; modulating the opening of tight junctions of the ocular epithelium; keratitis, conjunctivitis and dry eye syndrome
09/25/2012US8273378 Dialysis solutions containing pyrophosphates
09/25/2012US8273369 Reinforced absorbable synthetic matrix for hemostatic applications
09/25/2012US8273356 Anti-IgE vaccines
09/25/2012US8273331 Combination of medicament and lactose particles; accurate, uniform, consistent dispersion for multidose dry powder inhaler
09/25/2012CA2664137C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
09/25/2012CA2648109C Combination of an anti-ed-b fibronectin domain antibody-il-2 fusion protein and gemcitabine
09/25/2012CA2567400C Solid pharmaceutical formulation
09/25/2012CA2558985C Erythropoietin liquid formulation
09/25/2012CA2530983C Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
09/25/2012CA2512310C Improved linkers for radiopharmaceutical compounds
09/25/2012CA2443159C Liquid formulations for dermal application in treatment of parasitic insects in animals
09/25/2012CA2420768C Conjugates of defined stoichiometry
09/25/2012CA2389337C Reversibly inactivated acidified plasmin
09/25/2012CA2281594C Polysaccharide, micro-organism and method for obtaining same, composition containing it and application
09/22/2012CA2734662A1 Pharmaceutical composition containing tosufloxacin or salt thereof
09/20/2012WO2012126005A2 Polymer hydrogels for in vivo applications and methods for using and preparing same
09/20/2012WO2012125914A1 Injectable delivery system for heparan sulfate binding growth factors
09/20/2012WO2012125830A2 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
09/20/2012WO2012125552A2 Methods of electric field induced delivery of compounds, compositions used in delivery, and system of delivery
09/20/2012WO2012125486A1 Combination chemotherapy for treating cancer
09/20/2012WO2012125297A1 Porous disintegratable solid substrate for personal health care applications
09/20/2012WO2012125214A1 Topical nitric oxide systems and methods of use thereof
09/20/2012WO2012124998A2 Bio-pin
09/20/2012WO2012124869A1 Drug delivery system including laminated structure
09/20/2012WO2012124838A1 Amphiphilic pha-mpeg copolymer nanocontainers for drug delivery
09/20/2012WO2012124827A1 Binder for tablet forming
09/20/2012WO2012124688A1 Vector for pulmonary delivery, inducing agent, and uses
09/20/2012WO2012124214A1 Intraoral retaining agent for animal use, intraoral environment-improving agent for animal use, and intraoral environment-improving method for animal use
09/20/2012WO2012123926A1 Method for preparing multiple antigen glycopeptide carbohydrate conjugates
09/20/2012WO2012123755A1 Re-directed immunotherapy
09/20/2012WO2012123720A1 Colonoscopy - preparation
09/20/2012WO2012123515A1 An ophthalmic composition
09/20/2012WO2012123384A1 Improvements to immobilised biological entities
09/20/2012WO2012123275A1 Thermo-responsive hydrogel compositions
09/20/2012WO2012123269A1 Immunogenic compositions and methods for their use
09/20/2012WO2012122807A1 Process for synthesizing medical biodegradable polylactic acid by creatinine catalysed lactic acid condensation
09/20/2012WO2012103016A3 Extended-release beta agonist/anticholinergic transdermal patches and methods for using the same
09/20/2012WO2012094512A3 Myocardial tissue targeting peptides
09/20/2012US20120239007 Implantable Devices and Methods for Treatment of Pain by Delivery of Fentanyl and Fentanyl Congeners
09/20/2012US20120238747 Transfection reagents
09/20/2012US20120238644 Fragmented Hydrogels